Key Players
Competitive Landscape
Four business models define competition in sunscreen filter boosters: UV-filter producers and film-former specialists plus rheology companies and formulation-support groups. Their positions differ by how directly they influence filter architecture and how much application work they provide before claim testing.
Two formulation-focused launches in early 2025 made the shift toward full-formula performance visible to brands comparing booster technologies. Clariant launched the Eclipsogen CAP encapsulated UV-filter series in March 2025 to improve filter dispersion and film uniformity. Lubrizol introduced PemuPur VISTA polymer in April 2025 for skin-care and sun-care formulas that need simpler emulsion processing. Brand teams now compare stability evidence and processing flexibility beside nominal SPF improvement during ingredient selection.
Company developments mapped to drivers, trends and opportunities (2026-2036)
| Development | Driver | Trend | Opportunity |
|---|---|---|---|
| BASF launched new Cutina Shine UV-enhancing film-former data in September 2025 at the Florida sunscreen symposium. | Brands want measurable SPF support without sacrificing skin feel. | Performance data is moving closer to formulation and sensory evaluation. | Sell film-support systems into premium daily sunscreen development. |
| Elementis debuted NATURALUXE™ MFF in October 2025 as a biodegradable multifunctional film former tailored for light-texture sunscreens. | Formulators need water resistance and SPF retention in lighter sunscreen textures. | Film-former selection is moving closer to finished-format performance. | Supply film-former packages for lightweight sunscreen and hybrid beauty programs. |
| DSM-Firmenich announced Health Canada approval for PARSOL Shield in February 2026 at concentrations up to 6%. | Brands need more filter choices for multifunctional products. | Regulatory expansion is widening eligible broad-spectrum architectures. | Pair newly permitted filters with solvents and film-support packages. |
Symrise and Evonik compete outside the three-row development map on UV-filter breadth and SPF film technology. Ashland focuses on sun-care polymer expertise for film control and formulation support in finished sunscreen vehicles.
Source: Future Market Insights, Sunscreen Filter Boosters Market and Sun Care Products Market Reports, 2026-2036.
Leading companies collectively cover active-filter choice and film continuity alongside mineral dispersion, rheology and sensory modification for daily or high-protection sunscreen programs.
Who leads the Sunscreen Filter Boosters Market?
Symrise and DSM-Firmenich hold the broadest documented UV-filter positions while BASF also pairs filter breadth with digital formulation support for sunscreen development.
Which suppliers have documented qualification or quality approvals?
DSM-Firmenich documented Health Canada approval for PARSOL Shield in February 2026 at concentrations up to 6%. Clariant’s March 2025 Eclipsogen CAP launch provides formulation evidence but not a comparable regulatory approval.
Which companies provide film-forming or dispersion-boosting products?
Croda and Evonik provide direct film-performance technologies while Ashland and Clariant address film formation or rheology inside sunscreen vehicles.
Which suppliers serve North America and Asia?
DSM-Firmenich and BASF maintain international personal-care operations that cover North America and Asia. Ashland and Croda also serve both regions within their wider commercial networks.
Representative Company Overview
| Company | Positioning | Verified Development |
|---|---|---|
| Inolex | Independent sun-care ingredient developer focused on filter solubilization, film formation, and sensory performance. | In June 2026, introduced LexFeel® Enhance MB to stabilize bemotrizinol and other organic UV filters in high-SPF sunscreens. |
| Lubrizol | Specialty polymer company serving rheology and emulsion design in sun-care vehicles. | In April 2025, introduced Carbopol® BioSense polymer with documented compatibility for organic UV filters and low zinc oxide loads. |
| Ashland | Film-former and personal-care ingredient company with documented sun-care operations. | In April 2026, filed its Form 10-Q confirming sun care within its Personal Care business and continued high-performance ingredient activity. |
| Elementis | Mineral rheology and film-former specialist serving sun-care and hybrid beauty formulations. | In March 2026, announced BENTONE® LUXE DM as a new stabilizing and emulsifying gel for suncare and hybrid beauty formulations. |
| DSM-Firmenich | Global UV-filter producer with regulatory and formulation support capabilities. | In August 2026, announced the FDA effective date for PARSOL® Shield and its availability for USA sunscreen formulations. |
| BASF | Global UV-filter and formulation-development group with laboratory and digital support. | In October 2025, introduced Uvinul® TS Hydro, a water-soluble UVA filter designed for lighter sun-care formulations. |
| Croda | Market-edge specialty ingredient group with film and formulation technologies plus regional beauty laboratories. | In June 2026, commissioned its Guangzhou Hub to strengthen beauty formulation collaboration and regional technical support in China. |
| Momentive Performance Materials | Adjacent personal-care materials company with elastomer and film-former technologies used in sunscreen formulations. | In April 2025, launched HARMONIE™ NatuVel gel for skin care, suncare and color cosmetics at in-cosmetics Global. |
The companies mapped here illustrate the sunscreen filter boosters market structure rather than an exhaustive ranking. Inclusion requires current verifiable evidence that each company supplies UV filters or formulation ingredients that improve sunscreen-filter efficiency within the defined market scope. Evidence comes from regulatory approvals and company announcements plus technical documentation, third-party certifications or public filings tied to the stated sun-care product family. Capabilities are attributed to each documented sun-care platform or formulation program instead of broader corporate portfolios, while market-share estimates remain proprietary FMI assessments for the forecast period.
